Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to today's earnings call for Omeros Corporation.
Omeros Corp (OMER)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 18,033,000 | $54,031,376 | +11% | 0.77% | |
| 2. | 15,614,000 | $46,594,898 | +7% | 1.53% | |
| 3. | 13,380,000 | $40,266,187 | 0.02% | ||
| 4. | 950,000 | $16,316,252 | 1.27% | ||
| 5. | D E Shaw D. E. Shaw | 754,999 | $12,967,108 | -25% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.68 | 15,000 | $25,200.00 | 123,945 | 2023-11-17 | Filing | |
| $1.53 | 10,000 | $15,300.00 | 208,516 | 2023-11-15 | Filing | |
| $12.68 | 3,962 | $50,238.16 | 185,182 | 2015-09-04 | Filing | |
| $16.20 | 6,153 | $99,704.44 | 181,220 | 2014-06-24 | Filing | |
| $5.72 | 40,000 | $228,800.00 | 186,872 | 2013-01-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.31 | 30,000 | $369,315.00 | 0 | 2026-01-13 | Filing | |
| $12.72 | 30,000 | $381,600.00 | 0 | 2026-01-12 | Filing | |
| $6.46 | 5,000 | $32,300.00 | 0 | 2023-05-22 | Filing | |
| $6.53 | 5,000 | $32,650.00 | 35,067 | 2023-05-22 | Filing | |
| $14.90 | 36,857 | $549,169.30 | 2,026,986 | 2021-06-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 263,556 | $2,783,152 | 0.06% | |
| 2. | 59,500 | $628,320 | 0.17% | |
| 3. | 26,993 | $285,046 | 0% | |
| 4. | 22,860 | $241,402 | 0.05% | |
| 5. | 14,288 | $192,031 | 0% |
News See All
Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz
Latest reports show that Omeros Corporation (NASDAQ:OMER) has closed a deal worth around $2.1 billion with drug giant Novo Nordisk for the zaltenibart, a phase 2 asset of the former, in development for...
11 Best Micro-Cap Stocks to Invest in According to Analysts
Micro-cap companies, generally referring to publicly traded businesses with less than $300 million in market capitalization, are among the most volatile and high-risk investments in the stock market.
Do You Believe Omeros Corporation’s (OMER) New Monoclonal Antibody Has Strong Chances of Approval?
Jacob Fund is a mutual fund company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Omeros Corporation (NASDAQ:OMER) Q3 2025 Earnings Call Transcript
Operator: Thank you for your patience. Today's conference call will begin momentarily. Good afternoon. And welcome to today's earnings call for Omeros Corporation.
Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential?
Omeros Corporation (NASDAQ:OMER) is one of the hot stocks to buy with huge upside potential. On October 15, H.C.
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk
Omeros Corporation (NASDAQ:OMER) is one of the Reddit stocks that will go to the moon.
12 Reddit Stocks That Will Go to the Moon
On October 14, Ryan Detrick, Carson Group, joined CNBC's 'Closing Bell' to discuss what to make of the market's seasonal pullback and how the October volatility is perfectly normal.
Omeros Corporation (NASDAQ:OMER) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to today's earnings call for Omeros Corporation.
Hedge Fund Resource Center